Coltene Holding AG
SIX:CLTN

Watchlist Manager
Coltene Holding AG Logo
Coltene Holding AG
SIX:CLTN
Watchlist
Price: 52.1 CHF -0.19% Market Closed
Market Cap: 311.6m CHF

Coltene Holding AG
Minority Interest

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Coltene Holding AG
Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Coltene Holding AG
SIX:CLTN
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcon AG
SIX:ALC
Minority Interest
$16m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medartis Holding AG
SIX:MED
Minority Interest
CHf15.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IVF Hartmann Holding AG
SIX:VBSN
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Coltene Holding AG
Glance View

Market Cap
311.3m CHF
Industry
Health Care

Coltene Holding AG is engaged in the development, production, and sale of tools and equipment of dental consumables. The company is headquartered in Altstaetten, St. Gallen and currently employs 1,242 full-time employees. The company went IPO on 2006-06-23. The company develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. The company has production facilities in Switzerland, the United States, Germany and Hungary. The firm's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.

CLTN Intrinsic Value
101.31 CHF
Undervaluation 49%
Intrinsic Value
Price

See Also

Back to Top